Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -411.49%-1.39M | 96.46%-18.98K | 1,785.40%7.4M | 26.93%-1.28M | 89.09%-27.77K | -72.41%-271.87K | -19.56%-536.52K | 50.35%-439.18K | -17.67%-1.75M | -55.27%-254.46K |
| Net income from continuing operations | 100.28%1.68K | -71.36%-1.15M | -197.83%-849.03K | 1.17%-2.32M | -9.05%-758.6K | -32.53%-603.43K | -6.01%-673.83K | 49.27%-285.07K | -56.77%-2.35M | -12.44%-695.64K |
| Operating gains losses | -20,526.64%-49.84K | -98.96%5.65K | 100.39%2.12K | -1,760.56%-826.83K | -1,362.84%-824.12K | -99.69%244 | 1,040.61%543.35K | -1,370.30%-546.31K | 103.64%49.79K | -53.53%65.26K |
| Remuneration paid in stock | -86.31%43.65K | -77.61%71.48K | -52.18%102.76K | 484.70%1.51M | 3,413.27%659.86K | 639.44%318.86K | 381.65%319.24K | 64.60%214.9K | -80.34%258.74K | -79.71%18.78K |
| Other non cashItems | -1,027.29%-154.88K | 101.44%11.87K | -92.04%16.32K | -85.95%38.48K | 102.86%643.2K | -8.84%16.7K | -695.85%-826.45K | 202.41%205.03K | 548.70%273.89K | 1,600.98%317.07K |
| Change In working capital | -28,889.33%-1.23M | 934.63%1.05M | 29,412.02%8.13M | 1,453.05%321.08K | 528.65%251.89K | -102.71%-4.25K | 154.96%101.17K | 87.15%-27.74K | -83.70%20.67K | -83.50%40.07K |
| -Change in receivables | --18.89K | ---21.4K | --0 | --0 | --0 | --0 | --0 | --0 | -103.04%-122 | -86.57%4.88K |
| -Change in prepaid assets | 233.15%84.32K | -418.07%-74.3K | 34,015.89%7.88M | 1,147.07%4.47K | -6.92%21.35K | 3.24%-63.33K | 5.25%23.36K | 16.09%23.09K | 93.85%-427 | -67.69%22.94K |
| -Change in payables and accrued expense | -4,431.20%-1.33M | 586.38%1.14M | 407.80%156.45K | 228.63%316.61K | 7,066.30%230.54K | -112.78%-29.45K | 929.80%166.34K | 66.90%-50.83K | 178.39%96.34K | 103.12%3.22K |
| -Change in other working capital | --0 | --700 | --94.86K | ---- | ---- | ---- | ---- | ---- | -129.73%-75.12K | -96.22%9.03K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -411.48%-1.39M | 96.46%-18.98K | 1,785.40%7.4M | 26.93%-1.28M | 89.09%-27.77K | -72.41%-271.87K | -19.56%-536.52K | 50.35%-439.18K | -17.67%-1.75M | -55.27%-254.46K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 6.02%-5.87M | -22.50%-15.24M | -141.09%-3.41M | 96.82%-893.57K | 147.99%9.5M | -27.36%-6.25M | -1,006.62%-12.44M | 274.73%8.29M | 61.38%-28.08M | 26.32%-19.8M |
| Net PPE purchase and sale | -26.42%-8M | -5.51%-6.46M | 48.82%-4.97M | 16.59%-33.76M | -27.49%-11.6M | 45.95%-6.33M | 24.35%-6.12M | 16.15%-9.7M | 18.02%-40.47M | 29.69%-9.1M |
| Net intangibles purchas and sale | ---- | ---- | --0 | --10.52M | ---- | ---- | ---- | --10.52M | --0 | ---- |
| Net investment purchase and sale | --0 | -312.44%-8.91M | --0 | 35.88%16.57M | 180.16%8.73M | -156.41%-3.84M | -55.69%4.19M | 9.63%7.48M | 152.29%12.2M | 21.79%-10.89M |
| Net other investing changes | --2.13M | --127.7K | 20,024.99%1.56M | 2,851.83%5.77M | --1.85M | ---- | ---- | ---7.83K | --195.39K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 6.02%-5.87M | -22.50%-15.24M | -141.09%-3.41M | 96.82%-893.57K | 147.99%9.5M | -27.36%-6.25M | -1,006.62%-12.44M | 274.73%8.29M | 61.38%-28.08M | 26.32%-19.8M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -62.06%2.43M | 20,223.92%37.93M | -2.8K | -97.80%481.15K | -127.98%-6.1M | 58,710.13%6.4M | 186.64K | 0 | -67.90%21.84M | -36.66%21.8M |
| Net issuance payments of debt | 207.48%4.52K | -106.12%-11.41K | ---2.8K | --191.3K | --8.87K | ---4.21K | --186.64K | --0 | --0 | --0 |
| Net common stock issuance | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -67.13%21.64M | -36.67%21.64M |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | -5.45%194.89K | 16.87%194.89K | --0 | --0 | --0 | -90.72%206.13K | -35.31%166.76K |
| Net other financing activities | ---- | ---- | ---- | --94.97K | ---6.3M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -62.06%2.43M | 20,223.92%37.93M | ---2.8K | -97.80%481.15K | -127.98%-6.1M | 58,710.13%6.4M | --186.64K | --0 | -67.90%21.84M | -36.66%21.8M |
| Net cash flow | ||||||||||
| Beginning cash position | 1,445.13%32.24M | 103.54%9.17M | -22.84%5.39M | -53.38%6.99M | -61.39%2.03M | -79.73%2.09M | -51.73%4.51M | -53.38%6.99M | -28.80%14.99M | -29.66%5.25M |
| Current changes in cash | -3,815.27%-4.83M | 1,020.13%22.67M | 261.41%3.99M | 78.85%-1.69M | 92.80%3.37M | 97.56%-123.49K | -366.85%-2.46M | 55.86%-2.47M | -30.11%-7.98M | -76.31%1.75M |
| Effect of exchange rate changes | -1,722.92%-1.06M | 796.34%396.96K | -2,942.47%-208.96K | 592.25%92.24K | 38.86%-10.6K | 478.77%65.42K | 23.51%44.29K | 85.86%-6.87K | -126.31%-18.74K | -113.26%-17.34K |
| End cash Position | 1,198.70%26.35M | 1,445.13%32.24M | 103.54%9.17M | -22.84%5.39M | -22.84%5.39M | -61.39%2.03M | -79.73%2.09M | -51.73%4.51M | -53.38%6.99M | -53.38%6.99M |
| Free cash from | -41.49%-9.39M | 2.70%-6.48M | 123.96%2.43M | 16.89%-35.09M | -24.32%-11.63M | 44.07%-6.63M | 22.05%-6.66M | 18.42%-10.16M | 16.98%-42.22M | 28.63%-9.36M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.